About Genoplex.ai

Genoplex.ai has developed the Advanced Therapy Connect platform, an AI-powered data engine that streamlines patient referrals to advanced therapies such as cell and gene therapies. This technology reduces wait times and logistical barriers, enabling faster access to potentially curative treatments for patients.

```xml <problem> Patients requiring advanced therapies, such as cell and gene therapies, often face delays due to inefficient referral processes and logistical complexities. Traditional referral methods rely on outdated communication channels, leading to prolonged wait times and potential negative impacts on clinical outcomes. </problem> <solution> Genoplex.ai's Advanced Therapy Connect platform streamlines patient referrals to advanced therapy centers using an AI-powered data engine. The platform digitizes and automates the referral process, reducing logistical barriers and accelerating access to potentially curative treatments. By matching patient diagnostic information with approved therapies and clinical trials, the system ensures that patients are connected with the most appropriate treatment options. The cloud-based application provides real-time automated treatment notifications and facilitates faster intake processes at hospital treatment centers. This enables healthcare providers to make more informed decisions, improves patient experience, and supports efficient allocation of advanced therapies. </solution> <features> - AI-powered algorithm matches patient diagnostic data with relevant advanced therapies and clinical trials. - Cloud-based platform accessible without software downloads. - HIPAA, SOC 2, and GDPR compliant for healthcare data privacy. - Real-time referral visibility for improved demand forecasting and capacity planning. - Automated treatment notifications to keep patients informed throughout the process. - Streamlined patient intake process at hospital treatment centers. </features> <target_audience> The primary target audience includes healthcare providers in community practices referring patients for advanced therapies, hospital treatment centers, and life science companies. </target_audience> ```

What does Genoplex.ai do?

Where is Genoplex.ai located?

Genoplex.ai is based in Boulder, United States.

When was Genoplex.ai founded?

Genoplex.ai was founded in 2023.

Who founded Genoplex.ai?

Genoplex.ai was founded by Christopher Leidli.

Christopher Leidli - CEO/Founder

Location

Boulder, United States

Founded

2023

Employees

3 employees

Looking for specific startups?

Try our free semantic startup search

Genoplex.ai

Score: 42/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

genoplex.ai 200+

Founded 2023 – Boulder, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Christopher Leidli

CEO/Founder

Company Description

Problem

Patients requiring advanced therapies, such as cell and gene therapies, often face delays due to inefficient referral processes and logistical complexities. Traditional referral methods rely on outdated communication channels, leading to prolonged wait times and potential negative impacts on clinical outcomes.

Solution

Genoplex.ai's Advanced Therapy Connect platform streamlines patient referrals to advanced therapy centers using an AI-powered data engine. The platform digitizes and automates the referral process, reducing logistical barriers and accelerating access to potentially curative treatments. By matching patient diagnostic information with approved therapies and clinical trials, the system ensures that patients are connected with the most appropriate treatment options. The cloud-based application provides real-time automated treatment notifications and facilitates faster intake processes at hospital treatment centers. This enables healthcare providers to make more informed decisions, improves patient experience, and supports efficient allocation of advanced therapies.

Features

AI-powered algorithm matches patient diagnostic data with relevant advanced therapies and clinical trials.

Cloud-based platform accessible without software downloads.

HIPAA, SOC 2, and GDPR compliant for healthcare data privacy.

Real-time referral visibility for improved demand forecasting and capacity planning.

Automated treatment notifications to keep patients informed throughout the process.

Streamlined patient intake process at hospital treatment centers.

Target Audience

The primary target audience includes healthcare providers in community practices referring patients for advanced therapies, hospital treatment centers, and life science companies.